Yahoo Web Search

Search results

    • Q1 2024 Blueprint Medicines Corp Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 2 hours ago

      This is exactly what we expected based on advocates benefit risk profile. Q1 tends to be a tough quarter in our industry with patients benefits reverifications, lower gross to net and impact ...

    • Q1 2024 Agios Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 48 minutes ago

      And we look forward to presenting these data at an upcoming medical meeting as a reminder, non-transfusion dependent thalassemia accounts for approximately two thirds of Dallas ...